Phathom Pharmaceuticals, Inc. (PHAT)
6.92
-0.16
(-2.26%)
USD |
NASDAQ |
Oct 02, 16:00
6.85
-0.07
(-1.01%)
Pre-Market: 07:59
Phathom Pharmaceuticals EPS Diluted (Quarterly) : -0.2099 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2099 |
| March 31, 2026 | -0.3701 |
| December 31, 2025 | -0.2865 |
| September 30, 2025 | -0.4084 |
| June 30, 2025 | -1.046 |
| March 31, 2025 | -1.310 |
| December 31, 2024 | -1.048 |
| September 30, 2024 | -1.324 |
| June 30, 2024 | -1.562 |
| March 31, 2024 | -1.419 |
| December 31, 2023 | -1.389 |
| September 30, 2023 | -0.7616 |
| June 30, 2023 | -0.8446 |
| March 31, 2023 | -0.8928 |
| December 31, 2022 | -1.332 |
| Date | Value |
|---|---|
| September 30, 2022 | -1.316 |
| June 30, 2022 | -1.330 |
| March 31, 2022 | -1.069 |
| December 31, 2021 | -0.9488 |
| September 30, 2021 | -0.9829 |
| June 30, 2021 | -0.9977 |
| March 31, 2021 | -0.9599 |
| December 31, 2020 | -1.577 |
| September 30, 2020 | -1.022 |
| June 30, 2020 | -0.6395 |
| March 31, 2020 | -0.6203 |
| December 31, 2019 | -3.963 |
| September 30, 2019 | -2.777 |
| December 31, 2018 | -0.0197 |
| September 30, 2018 | -0.0118 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.58M |
| Revenue (Quarterly) | 74.27M |
| Total Expenses (Quarterly) | 91.86M |
| Enterprise Value | 923.63M |
| Gross Profit Margin (Quarterly) | 79.68% |
| Profit Margin (Quarterly) | -23.67% |
| Earnings Yield | -18.42% |
| Normalized Earnings Yield | -18.42 |